Delivery Order SPE2DB25D3306-SPE2DB25FUCVY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,500.48 to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packs of 50, with a ceiling value of $1,188.33. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Moxifloxacin HCl 400 mg tablets (30-count packaging) with a ceiling value of $1,596.49. This firm fixed-price delivery order is set to be completed by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without set-aside designation through competitive...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. This contract is valued at $2,070.00 with a firm fixed price structure and an ultimate completion date of August 20, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50s. This is a firm fixed price delivery order with a ceiling value of $1,852.51 and an ultimate completion date of August 18, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed from the vendor's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,282.08 on August 14, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packages of 50 units. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania....
- The Defense Department's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) valued at $1,428.34. This non-competitive, firm fixed-price delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,380.00 for Moxifloxacin HCL 400 mg tablet unit dose packs of 50 units. This firm fixed price, competitively awarded contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery order was fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, reflecting...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit-dose packaging of 50 tablets each. This delivery order, valued at $13,589.23, represents a firm fixed-price contract with an ultimate completion date of August 29, 2025. The award was made on a competitive basis with no set-aside provisions and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin hydrochloride 400 mg tablets in unit dose packaging of 50s, with a ceiling value of $2,070.00. Awarded on August 14, 2025, this firm fixed-price delivery order is due for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, consistent with...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCVYDelivery Order
The Defense Logistics Agency awarded a $1,364.93 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages). The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with a demonstrated capability to fulfill pharmaceutical procurement requirements across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/3/25 |